Table of Contents Author Guidelines Submit a Manuscript
International Journal of Surgical Oncology
Volume 2012, Article ID 297832, 5 pages
http://dx.doi.org/10.1155/2012/297832
Review Article

Atypical Ductal Hyperplasia at the Margin of Lumpectomy Performed for Early Stage Breast Cancer: Is there Enough Evidence to Formulate Guidelines?

1Division of General Surgery, Department of Surgery, UCSD Medical Center, University of California, San Diego, CA 92103, USA
2Division of Surgical Pathology and Cytopathology, Department of Pathology, UCSD Medical Center, University of California, San Diego, CA 92093, USA
3Division of Surgical Oncology and Breast Surgery, Department of Surgery, UCSD Moores Cancer Center, University of California, San Diego, CA 92093, USA

Received 10 August 2012; Accepted 29 October 2012

Academic Editor: Sheldon Marc Feldman

Copyright © 2012 Jennifer L. Baker et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Fisher, S. Anderson, J. Bryant et al., “Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer,” The New England Journal of Medicine, vol. 347, no. 16, pp. 1233–1241, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Simone, T. Dan, J. Shih, S. Smith et al., “Twenty-five year results of the National Cancer Institute randomized breast conservation trial,” Breast Cancer Research and Treatment, vol. 132, pp. 197–203, 2012. View at Google Scholar
  3. M. M. Poggi, D. N. Danforth, L. C. Sciuto et al., “Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute randomized trial,” Cancer, vol. 98, no. 4, pp. 697–702, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. Early Breast Cancer Trialists' Collaborative Group (EBCTCG), “Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials,” The Lancet, vol. 366, pp. 2087–2106, 2005. View at Google Scholar
  5. R. Arriagada, M. G. Lê, F. Rochard, and G. Contesso, “Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data,” Journal of Clinical Oncology, vol. 14, no. 5, pp. 1558–1564, 1996. View at Google Scholar · View at Scopus
  6. U. Veronesi, N. Cascinelli, L. Mariani et al., “Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer,” The New England Journal of Medicine, vol. 347, no. 16, pp. 1227–1232, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Litiere, G. Werutsky, I. Fentiman, and E. Rutgers, “Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC, 10801 phase 3 randomised trial,” The Lancet Oncology, vol. 13, no. 4, pp. 412–419, 2012. View at Google Scholar
  8. A. Taghian, M. Mohiuddin, R. Jagsi, S. Goldberg, E. Ceilley, and S. Powell, “Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey,” Annals of Surgery, vol. 241, no. 4, pp. 629–639, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Azu, P. Abrahamse, S. J. Katz, R. Jagsi, and M. Morrow, “What is an adequate margin for breast-conserving surgery? Surgeon attitudes and correlates,” Annals of Surgical Oncology, vol. 17, no. 2, pp. 558–563, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. S. L. Blair, K. Thompson, J. Rococco, V. Malcarne, P. D. Beitsch, and D. W. Ollila, “Attaining negative margins in breast-conservation operations: is there a consensus among breast surgeons?” Journal of the American College of Surgeons, vol. 209, no. 5, pp. 608–613, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. S. E. Singletary, “Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy,” American Journal of Surgery, vol. 184, no. 5, pp. 383–393, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. M. F. Dillon, A. D. K. Hill, C. M. Quinn, E. W. McDermott, and N. O'Higgins, “A pathologic assessment of adequate margin status in breast-conserving therapy,” Annals of Surgical Oncology, vol. 13, no. 3, pp. 333–339, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Luini, J. Rososchansky, G. Gatti et al., “The surgical margin status after breast-conserving surgery: discussion of an open issue,” Breast Cancer Research and Treatment, vol. 113, no. 2, pp. 397–402, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Morrow, J. Harris, and S. Schnitt, “Surgical margins in lumpectomy for breast cancer—bigger is not better,” The New England Journal of Medicine, vol. 367, no. 1, pp. 79–82, 2012. View at Google Scholar
  15. A. Demirci, G. Broadwater, M. Lawrence et al., “Breast conservation therapy: the influence of molecular subtype and margins,” International Journal of Radiation Oncology, vol. 83, no. 3, pp. 814–820, 2012. View at Google Scholar
  16. F. A. Vicini, N. S. Goldstein, H. Pass, and L. L. Kestin, “Use of pathologic factors to assist in establishing adequacy of excision before radiotherapy in patients treated with breast-conserving therapy,” International Journal of Radiation Oncology Biology Physics, vol. 60, no. 1, pp. 86–94, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. S. N. Goldstein, “Controversies in pathology in early-stage breast cancer,” Seminars in Radiation Oncology, vol. 21, no. 1, pp. 20–25, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Ghofrani, B. Tapia, and F. A. Tavassoli, “Discrepancies in the diagnosis of intraductal proliferative lesions of the breast and its management implications: results of a multinational survey,” Virchows Archiv, vol. 449, no. 6, pp. 609–616, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Nizre, S. Schneebaum, J. Klausner, and T. Menes, “Current Management practice of breast borderline lesions- need for further research and guidelines,” American Journal of Surgery, vol. 203, pp. 721–725, 2012. View at Google Scholar
  20. O. E. Young, K. Valassiadou, and M. Dixon, “A review of current practices in breast conservation surgery in the UK,” Annals of the Royal College of Surgeons of England, vol. 89, no. 2, pp. 118–123, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Rosai, “Borderline epithelial lesions of the breast,” American Journal of Surgical Pathology, vol. 15, no. 3, pp. 209–221, 1991. View at Google Scholar · View at Scopus
  22. S. J. Schnitt, J. L. Connolly, F. A. Tavassoli et al., “Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria,” American Journal of Surgical Pathology, vol. 16, no. 12, pp. 1133–1143, 1992. View at Publisher · View at Google Scholar · View at Scopus
  23. R. K. Jain, R. Mehta, R. Dimitrov et al., “Atypical ductal hyperplasia: interobserver and intraobserver variability,” Modern Pathology, vol. 24, no. 7, pp. 917–923, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. F. A. Tavassoli and H. J. Norris, “A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast,” Cancer, vol. 65, no. 3, pp. 518–529, 1990. View at Google Scholar · View at Scopus
  25. D. L. Page and L. W. Rogers, “Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia,” Human Pathology, vol. 23, no. 10, pp. 1095–1097, 1992. View at Publisher · View at Google Scholar · View at Scopus
  26. S. R. Lakhani, I. O. Ellis, S. J. Schnitt, P. H. Tan, and M. J. Van de Vijver, WHO Classification of Tumours of the Breast, 4th edition, 2012.
  27. T. M. A. Abdel-Fatah, D. G. Powe, Z. Hodi, J. S. Reis-Filho, A. H. S. Lee, and I. O. Ellis, “Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family,” American Journal of Surgical Pathology, vol. 32, no. 4, pp. 513–523, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Masood and M. Rosa, “Borderline breast lesions: diagnostic challenges and clinical implications,” Advances in Anatomic Pathology, vol. 18, no. 3, pp. 190–198, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. P. R. Eby, J. E. Ochsner, W. B. DeMartini, K. H. Allison, S. Peacock, and C. D. Lehman, “Frequency and upgrade rates of atypical ductal hyperplasia diagnosed at stereotactic vacuum-assisted breast biopsy: 9—versus II-gauge,” American Journal of Roentgenology, vol. 192, no. 1, pp. 229–234, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Costarelli, D. Compagna, M. Mauri et al., “Intraductal proliferative lesions of the breast—terminology and biology matter: premalignant lesion or preinvasive cancer,” International Journal of Surgical Oncology, vol. 2012, Article ID 501904, 9 pages, 2012. View at Publisher · View at Google Scholar
  31. D. L. Page, W. D. Dupont, L. W. Rogers, and M. S. Rados, “Atypical hyperplastic lesions of the female breast. A long-term follow-up study,” Cancer, vol. 55, no. 11, pp. 2698–2708, 1985. View at Google Scholar · View at Scopus
  32. W. J. Lennington, R. Jensen, L. Dalton, and D. Page, “Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions,” Cancer, vol. 73, no. 1, pp. 118–124, 1994. View at Google Scholar
  33. N. S. Goldstein, M. Lacerna, and F. Vicini, “Cancerization of lobules and atypical ductal hyperplasia adjacent to ductal carcinoma in situ of the breast: significance for breast-conserving therapy,” American Journal of Clinical Pathology, vol. 110, no. 3, pp. 357–367, 1998. View at Google Scholar · View at Scopus
  34. B. Fowble, A. L. Hanlon, A. Patchefsky et al., “The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation,” International Journal of Radiation Oncology Biology Physics, vol. 42, no. 1, pp. 105–115, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Greene, P. I. Tartter, S. R. Smith, and A. Estabrook, “The signficance of surgical margins for patients with atypical ductal hyperplasia,” American Journal of Surgery, vol. 192, no. 4, pp. 499–501, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Arora, T. S. Menes, C. Moung, C. Nagi, I. Bleiweiss, and S. Jaffer, “Atypical ductal hyperplasia at margin of breast biopsy—is re-excision indicated?” Annals of Surgical Oncology, vol. 15, no. 3, pp. 843–847, 2008. View at Publisher · View at Google Scholar · View at Scopus